Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Integrated Sensor Platform for Real-time Monitoring of Key Process Parameters and Critical Quality Attributes for Bioprocessing 4.0

Objective

ArgusEye is revolutionizing bioprocessing in the biopharmaceutical industry through provision of real-time data on critical process parameters and quality attributes. Biopharmaceuticals, or biologics, are becoming central to modern healthcare replacing small molecule drugs. However, this is hindered by availability issues in Europe, where biologics account for 60% of all drug shortages. Manufacturing costs for biologics are about 10 times higher than traditional pharma, with longer process development times extending time-to-market. Outdated manufacturing practice is a major issue as bioprocessing is still performed stepwise with intermediate offline laboratory checks to obtain critical process and quality parameters. Such a paradigm extends production time, hampers process automation and leads to an increased environmental footprint. ArgusEye addresses the status quo with its pioneering nanoplasmonic detection technology, enabling real-time, in-line monitoring of critical process and quality parameters across the entire bioprocess chain. Our Auga platform technology replaces outdated time-consuming laboratory methods, accelerating biologics process development with a potential to reduce OPEX/CAPEX through transition to continuous manufacturing. The solution enhances biologics availability by cutting manufacturing costs and shortening time-to-market, while significantly improving sustainability through decreased process mass intensity. The Auga platform is well suited to address the EU’s Pharmaceutical Strategy goals of improving access to biologics and the EU Green Deal's aim of enhancing sustainability in the industry. With EIC support, we aim to adapt our technology, build facilities for LSPR sensor chip manufacturing, and expand on markets, positioning ArgusEye as a global leader in real-time, plug-and-play analytical solutions for bioprocessing.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC - HORIZON EIC Accelerator

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2025-ACCELERATOR-02

See all projects funded under this call

Coordinator

ArgusEye AB
Net EU contribution
€ 2 499 975,63
Address
Fridtunagatan 24
582 13 Linköping
Sweden
SME
Yes
Region
Östra Sverige Östra Mellansverige Östergötlands län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data